Evidence map›Paper›PMID 19607717›Full record

ArticleMalaria journal2009

Temporal stability of naturally acquired immunity to Merozoite Surface Protein-1 in Kenyan adults.

Arlene E Dent, Kiprotich Chelimo, Peter O Sumba, Michele D Spring, Brendan S Crabb, Ann M Moormann, Daniel J Tisch, James W Kazura

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 47 citations in OpenAlex.

  1. Trial
  2. Regulatory T cell memory: implications for malaria.Journal of immunology (Baltimore, Md. : 1950) · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Interferon-PeerJ · 2017
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Arlene E DentCase Western Reserve University, Cleveland, OH, USA. arlene.dent@case.edu
Kiprotich Chelimo
Peter O Sumba
Michele D Spring
Brendan S Crabb
Ann M Moormann
Daniel J Tisch
James W Kazura
Case Western Reserve University · USKenya Medical Research Institute · KEBurnet Institute · AUWalter Reed Army Institute of Research · US

Funding

Human immunity to MSP-1 in Western KenyaR01AI043906 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI KAZURA, JAMES WALTER · 2004 to 2008
$3.0M
CWRU-Kenya Infectious Diseases Research Training ProgramD43TW006576 · FIC · CASE WESTERN RESERVE UNIVERSITY · PI KING, CHARLES HARDING · 2003 to 2008
$830k
FIC NIH HHS 1D43TW006576FIC NIH HHS D43 TW006576NIAID NIH HHS R01 AI043906NIAID NIH HHS R01 AI43906
6 · The paper itself

Abstract

backgroundNaturally acquired immunity to blood-stage Plasmodium falciparum infection develops with age and after repeated infections. In order to identify immune surrogates that can inform vaccine trials conducted in malaria endemic populations and to better understand the basis of naturally acquired immunity it is important to appreciate the temporal stability of cellular and humoral immune responses to malaria antigens.

methodsBlood samples from 16 adults living in a malaria holoendemic region of western Kenya were obtained at six time points over the course of 9 months. T cell immunity to the 42 kDa C-terminal fragment of Merozoite Surface Protein-1 (MSP-1(42)) was determined by IFN-gamma ELISPOT. Antibodies to the 42 kDa and 19 kDa C-terminal fragments of MSP-1 were determined by serology and by functional assays that measure MSP-1(19) invasion inhibition antibodies (IIA) to the E-TSR (3D7) allele and growth inhibitory activity (GIA). The haplotype of MSP-1(19) alleles circulating in the population was determined by PCR. The kappa test of agreement was used to determine stability of immunity over the specified time intervals of 3 weeks, 6 weeks, 6 months, and 9 months.

resultsMSP-1 IgG antibodies determined by serology were most consistent over time, followed by MSP-1 specific T cell IFN-gamma responses and GIA. MSP-1(19) IIA showed the least stability over time. However, the level of MSP-1(19) specific IIA correlated with relatively higher rainfall and higher prevalence of P. falciparum infection with the MSP-1(19) E-TSR haplotype.

conclusionVariation in the stability of cellular and humoral immune responses to P. falciparum blood stage antigens needs to be considered when interpreting the significance of these measurements as immune endpoints in residents of malaria endemic regions.

Indexed as

AdolescentAdultAgedAllelesAnimalsAntibodies, ProtozoanEnzyme-Linked Immunosorbent AssayFemaleHaplotypesHumansImmunity, InnateImmunoglobulin GInterferon-gammaKenyaMalaria, FalciparumMaleAntibodies, ProtozoanImmunoglobulin GInterferon-gammaMerozoite Surface Protein 1Protein Subunits

Identifiers

PMID19607717
PMCPMC2719655
OpenAlexW2097193246

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.